Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Q: Paragraph: The Texas woman’s name is Cathy Flanders and she has been on a crusade to bring the problem of indoor pollution from candles to the forefront. She has filed a lawsuit against the store that sold her candles which she says resulted in toxic levels of lead in her home and with serious medical consequences on her family. Regardless of the merits of her case, it is true that indoor pollution from certain kinds of candles is becoming a focus of research and is one of the hot topics right now among professionals concerned with health issues in the home. Not all the researchers are focused on lead and there are some who say they feel the danger from lead is reduced by the fact that U.S. candle makers have not used lead in candles for more than 25 years. There is increased focus on what researchers say is a significant contribution of candles to soot residue in buildings, more than has previously been realized, and to what extent that soot can contribute to health problems. While that is being studied, pollution experts recommend choosing candles from U.S. manufacturers that are made of hard wax, have low aromatic properties, burn with a low, even flame and with wicks that burn down evenly with the rest of the candle. They also recommend keeping burning candles out of drafts and not allowing an extinguished candle to continue emitting smoke. For more information: CNN Article about Cathy Flanders Article about Black Soot in the Home from the Environmental Illness Society of Canada  Comments Claim:  An email is making the rounds that talks about a woman in Texas whose family has experienced a variety of health problems which she says are due to the lead content of some candles.  The email warns that burning candles in the home can lead to health problems.      

A: Beware of potential pollution from certain candles 
****
Q: Paragraph: "The story mentioned that the test carried a $399 price tag. Of course there are larger cost perspectives. If this diagnostic test truly has value, it might lead to more targeted therapy – perhaps decreasing overall medical costs. If it is a poor test, it may increase medical costs beyond the initial $399 for the test itself. The story included discussion about how this test might be of benefit; it did not include quantification of benefit (i.e. :how much faster could it enable a clinician to make a diagnosis?) though one of the points of the story was that the actual benefit of this test was somewhat imprecise. Lastly – the statement that any information is good is a red herring. However, we’ll again give the story the benefit of the doubt on this criterion. The story discussed problems associated with false positive or false negative results. It mentioned that physicians might not have the appropriate training to understand what to do with the results of the test and could make, what an expert quoted in the story described as ""foolish decisions"" The story mentioned that this and other genetic test kits prey on individuals’ deepest anxieties. That said – there are many more harms possible. Creating the precedent for direct marketing of lab tests – even if the results go to the doctor carries significant risks. It could prey on peoples’ insecurities, cause financial harm, adversely affect the patient-clinician relationship, and lead to other family members of test positive patients (family members without symptoms) getting a meaningless test due to worry. It was good that the story pointed out that there is little oversight for the accuracy of genetic test kits. Overall the story did a good job; it gave data such as 1% rate of genetic abnormality in unaffected vs. 3% in bipolar patients. It said, ""The report that accompanies those results instructs doctors that a positive test means patients are two to three times more likely to have bipolar disorder."" If the reporter had gone the next step, it would have been even better. For example, if someone has no symptoms of bipolar disorder, then the likelhood of current bipolar is 0% – so a 2-3 time increase in risk is still 0. For someone with many symptoms, the risk of bipolar disorder might be 50-60% (rough estimate) and an abnormal test might increase that substantially. Granted, interpreting the quantitative data for readers may be difficult but it would have been helpful to put it into terms that were easier to understand. But in discussing why the test was useful, the company founder said that it was important ""even if it just helps a little bit"". The story should have noted that this lack of quantification of benefit is problematic. We’ll give the story the benefit of the doubt on this criterion. The story did not engage in overt disease mongering. The story included quotes not only from the scientist who developed the test discussed, but from several experts in the field. The story did not make clear how diagnosis of bipolar disorder with the test vs. without the test differed. However it would appear that this may have been intentional as it isn’t actually clear how diagnosis of this disorder is dramatically altered in the era where this test is available. The story mentioned that this was a commercially available product. (Though it failed to mention that this test would likely not be covered by insurance, it also did not imply that it would. This, of course, will affect availability.) The story was clear that the test for bipolar disorder it described had been commercially available for about a month. It also mentioned that there about 1000 other test kits (for other genetic traits) which are available. Does not appear to rely on a press release." Claim: At-home gene test stirs up debate

A: This is an excellent story that used a concrete example (i.e. bipolar disorder) to highlight the pitfalls involved with the use of genetic test kits for gene alleles. Rather than write a story heralding the first commercial availability of a test to identify genetic markers associated with risk of bipolar disorder, this was a thoughtful piece that presented both the hope and the hype associated with the product. While failing to provide concrete estimates for the benefit from the product or diagnostic alternatives, the story painted an accurate picture of the uncertainty for deriving benefit.
****
Q: Paragraph: Unlike the all-out defense that Buxton normally puts on display, the Twins were more than willing to play it safe with this injury. Buxton was placed on the seven-day injured list for players with concussion-like symptoms, just as first baseman C.J. Cron and left fielder Eddie Rosario returned from their injuries. The Twins also designated right-handed reliever Mike Morin for release or assignment Tuesday before their series opener against the New York Mets. “We’re not going to mess around, really, in any way,” manager Rocco Baldelli said. “This is serious stuff. The health of Buck is obviously the most important thing. I think it’s something that is already resolving itself in some ways, but something where I think this is the right move.” Buxton was hurt Saturday during his head-first, diving catch of a sinking line drive during a critical win at main division competitor Cleveland, forcing him out of the game in the eighth inning. Buxton, who was sidelined for 13 games last month with a bruised right wrist, has had his promising career so far stunted by a variety of injuries, in part due to the speedster’s fearless style in the outfield and on the bases. Buxton was announced Tuesday as the team’s annual winner of the Major League Baseball Players Alumni Association’s Heart and Hustle Award. “He hit the ground pretty hard, and this isn’t any sort of light injury,” Baldelli said. “He didn’t graze anything. He made a great play and hit the ground, and he gives his body up for this team every single night that he takes the field.” The Twins, who took a six-game lead in the AL Central over the Indians into Tuesday night, have managed to maintain the highest-scoring offense in the majors despite putting 10 different position players on the injured list over various points of this season. Rosario was out for 13 games with a sprained left ankle. “It’s been a tough couple of weeks when it comes to injuries and things like that, but I’m back today and I know what Buxton is going through is nothing bad and he’ll be back soon as well,” said Rosario, who’s second on the team with 20 homers and still leads the Twins with 60 RBIs. Because of the All-Star break, Cron only missed five games with right thumb inflammation, a condition that has bothered him for most of the season. “I’m just going to try to tape it up, I guess. Try to pretend as if nothing’s wrong and try to just keep going,” Cron said. “That’s really all you can do.” Morin had a 3.18 ERA in 23 appearances after being invited to spring training on a minor league contract. His somewhat surprising removal from the roster could be the precursor to the addition of a reliever or two on the trade market over the next two weeks. “When you make decisions like this, you can look back on them, and you’re not really sure because things are not obvious sometimes, but unfortunately we landed on the thought of designating Mike,” Baldelli said. “I have no doubt he’s going to land on his feet.” ___ More AP baseball coverage: https://apnews.com/MLB and https://twitter.com/AP_Sports Claim: As Cron, Rosario return, Twins put Buxton on concussion list.

A:
The latest improbable catch by Byron Buxton caused a face-first crash into the grass, another painful highlight-reel grab for the Minnesota center fielder .
****